Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Acquisitions & Divestments (2023 - 2025)

Historic Change in Acquisitions & Divestments for Collegium Pharmaceutical (COLL) over the last 3 years, with Q3 2025 value amounting to $14.6 million.

  • Collegium Pharmaceutical's Change in Acquisitions & Divestments fell 5049.12% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.3 million, marking a year-over-year decrease of 3380.91%. This contributed to the annual value of $92.6 million for FY2024, which is 32091.82% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Change in Acquisitions & Divestments of $14.6 million as of Q3 2025, which was down 5049.12% from $13.8 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Change in Acquisitions & Divestments peaked at $29.4 million during Q3 2024, and registered a low of $13.8 million during Q2 2025.
  • Its 3-year average for Change in Acquisitions & Divestments is $19.2 million, with a median of $16.5 million in 2023.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first decreased by 15.0% in 2024, then plummeted by 5049.12% in 2025.
  • Collegium Pharmaceutical's Change in Acquisitions & Divestments (Quarter) stood at $16.0 million in 2023, then decreased by 0.15% to $16.0 million in 2024, then dropped by 8.83% to $14.6 million in 2025.
  • Its Change in Acquisitions & Divestments was $14.6 million in Q3 2025, compared to $13.8 million in Q2 2025 and $17.0 million in Q1 2025.